A Hochhaus1. Show Affiliations » 1. III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany.
Abstract
Entities: Disease
Mesh： See more » Antineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsBiomarkers, Tumor/geneticsClinical Trials as TopicDrug Therapy, CombinationFusion Proteins, bcr-ablHematologic Neoplasms/drug therapyHematologic Neoplasms/geneticsHematologic Neoplasms/metabolismHumansInhibitory Concentration 50Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolismLeukemia, Myelogenous, Chronic, BCR-ABL Positive/pathologyProtein-Tyrosine Kinases/antagonists & inhibitorsRandomized Controlled Trials as TopicTreatment Outcome
Substances： See more » Antineoplastic AgentsBiomarkers, TumorProtein-Tyrosine KinasesFusion Proteins, bcr-abl
Year: 2007 PMID： 17631597 DOI： 10.1093/annonc/mdm295
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976